Evidence map›Paper›PMID 39311373›Full record

ArticleMethods and protocols2024

Generating Cytokines and Growth Factors for Functional Activity: Feasibility of Method Using MIF Protein.

Hiba Osmani, Ishrya Sharma, Shannon Moonah

Abstract read
In one paragraph

Article in Methods and protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hiba OsmaniDepartment of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
Ishrya SharmaDepartment of Medicine, University of Florida, Gainesville, FL 32608, USA.
Shannon MoonahDepartment of Medicine, University of Florida, Gainesville, FL 32608, USA.

Funding

CD74 and Wound HealingR01DK131313 · NIDDK · UNIVERSITY OF VIRGINIA · PI Shannon Moonah · 2022 to 2026
$1.8M
National Institutes of Health (NIH) R01DK131313NIDDK NIH HHS R01 DK131313the Hartwell Foundation
6 · The paper itself

Abstract

Cytokines and growth factors are signaling molecules that regulate a variety of biological processes. Understanding their role is essential for basic research and clinical utilization. Thus, cytokines and growth factors are widely used throughout research labs in a significant number of applications. Additionally, genetic polymorphisms result in variant forms of cytokines and growth factors, which can alter their function. Becoming more common, researchers will need to generate these important proteins and their variants themselves in functional forms for activity studies. The expression systems used to generate these proteins can have a major impact on their function. In some instances, post-translational modifications are needed to produce a functionally active protein, which can only be conducted using eukaryotic expression systems. Ideally, for functional relevance, a human expression system should be used for human-related research and applications. Most human cell-based expression systems primarily use HEK (Human Embryonic Kidney) cells; however, relying on just one cell type can lead to several issues, considering the variety of proteins derived from various cell sources. Here, we provide a protocol to effectively and efficiently generate functional recombinant proteins, taking into consideration the diverse range of proteins from different cell types throughout the human body.

Indexed as

cytokinesfunctional proteinsgrowth factorshuman expression system

Identifiers

PMID39311373
PMCPMC11417903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.